Licensed U.S. Pet Pharmacy | Verified Pharmacy
SAVE 20% OFF 20% OFF Use Code EASTER20 *
Modulis (Cyclosporine) Oral Solution for Cats - 100mg/mL (4.7mL)
Item# MWI125271
FREE SHIPPING Over $79! * Pet Food & Other Exclusions
- Description
- Ingredients
- Directions
- Reviews
Description
Modulis for Cats is a prescription oral solution designed to manage chronic allergic and immune-mediated skin conditions in felines. Containing Cyclosporine USP (Modified) — the same active ingredient found in Atopica — this immunosuppressant helps control the underlying immune response that leads to itching, redness, and inflammation. The liquid formulation ensures precise dosing and easy administration, especially for cats that may resist capsules. With regular use under veterinary supervision, Modulis supports healthier skin and long-term comfort in cats with persistent dermatologic conditions.
- Prescription immunosuppressant for managing chronic atopic dermatitis
- Active ingredient: Cyclosporine USP (Modified) — generic alternative to Atopica
- Helps reduce itching, redness, and inflammation caused by allergic skin conditions
- Targets the root immune response rather than just relieving symptoms
- Ideal for pets that have difficulty swallowing capsules
- Requires veterinary supervision for safe and effective use
Ingredients
Key Ingredients:
Cyclosporine USP (Modified) - 100 mg/mL
| Vial / Bottle Content | Syringes |
|---|---|
| 4.7 mL | 1 mL |
| 15 mL | 1 mL |
Directions
Directions for Use:
- Dosage: Administer as directed by your veterinarian.
- Administration: Give orally, either directly or mixed with a small amount of food.
- Consistency: Administer at the same time each day to help maintain consistent blood levels.
- Monitoring: Regular veterinary check-ups are recommended to monitor progress and adjust dosage if needed.
Warnings:
MODULIS for Cats is a systemic immunosuppression that may increase the susceptibility to infection and the development of neoplasia. One of 205 field study cats died of the effusive form of feline infectious peritonitis. Persistent, progressive weight loss that resulted in hepatic lipidosis occurred in 2 of 205 cats on treatment with cyclosporine in field studies. Monitoring of body weight is recommended.
